
                     
                     
                     Drug Interactions
                     
                        
                           
                              Anticoagulants: C-17 substituted derivatives of testosterone, such  as methandrostenolone, have been  reported to decrease the  anticoagulant requirements of patients receiving oral anticoagulants. Patients receiving oral anticoagulant therapy require close monitoring, especially when androgens are started or stopped.
                           
                              Oxyphenbutazone: Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone.
                           
                              Insulin:  In diabetic patients, the metabolic effects of androgens may decrease blood  glucose and insulin requirements.
                        
                     
                     
                  
               